Webcast / Audiocast

0 Comments

31 March 2017

Partner 2 Trial: Transcatheter or Surgical Aortic-Valve Replacement in Intermediate risk patients

Dr Michael Cunnington

Leeds Teaching Hospital

Previous | Next

Summary

Dr Cunnington outlines findings from the recently published PARTNER 2 Trial (NEJM) comparing TAVI to SAVR in the intermediate risk cohort.

Summary

Dr Cunnington outlines findings from the recently published PARTNER 2 Trial (NEJM) comparing TAVI to SAVR in the intermediate risk cohort.

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In